KYLE HOUSE GROUP lobbying for US PHARMACOPEIA

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

Maryland

Official filing document

Lobbyists on this filing 1

JULIAN FLEISCHMAN

Previously held: Senior Legislative Assistant, Rep. Peter Meijer; Legislative Assistant, Rep. Briab Mast

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Foreign Relations

Education and advocacy in support of global health, global medical supply chains, and quality assurance programs. House and Senate FY27 State Foreign Operations Bills: H.R. 8595, the National Security, Department of State, and Related Programs Appropriations Act, 2027; H.R. 9770, the Continuing Appropriations Act, 2027; H.R. 6500, the Continuing Appropriations and Extensions Act, 2027

Health Issues

Education and advocacy in support of global health, global medical supply chains, and quality assurance programs. House and Senate FY27 State Foreign Operations Bills: H.R. 8595, the National Security, Department of State, and Related Programs Appropriations Act, 2027; H.R. 9770, the Continuing Appropriations Act, 2027; H.R. 6500, the Continuing Appropriations and Extensions Act, 2027

Bills named in this filing 3

H.R. 8595
National Security, Department of State, and Related Programs Appropriations Act, 2027
H.R. 9770
Continuing Appropriations Act, 2027
H.R. 6500
Continuing Appropriations and Extensions Act, 2027